<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">
hero-press-releases-1

Newsroom

Press Releases

Our latest announcements

Posts in: lung cancer biomarkers

Biodesix® Tests Demonstrate Ability to Stratify Patients Treated with Immunotherapy

Biodesix presents data at the World Lung Conference showing the ability to stratify lung cancer patients treated with immunotherapy

Horizon Blue Cross Blue Shield of New Jersey Provides Coverage for Biodesix’ VeriStrat Test

Horizon Blue Cross Blue Shield (BCBS) of New Jersey has determined that the VeriStrat® proteomic test is now considered a medically necessary benefit for members with advanced NSCLC.